Board declares Interim Dividend
Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at their meeting held on January 28, 2017, inter alia, has decided to pay an interim dividend of Rs. 5/- (Rupees Five only) per share for the financial year 2016-17. Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2016
Thyrocare Technologies Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Consolidated Financial Results for the period ended December 31, 20163. Standalone Limited Review for the period ended December 31, 20164. Consolidated Limited Review for the period ended December 31, 2016 Board to consider Interim Dividend
Thyrocare Technologies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 28, 2017, inter alia, to consider, the Unaudited Stand-alone as well as Consolidated financial results of the Company for the quarter / nine months ended December 31, 2016.The Board will also consider payment of interim dividend, if any, after taking into consideration the capital expenditure and other cash requirements... Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Thyrocare Technologies Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended December 31, 2016
Thyrocare Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Updates
Thyrocare Technologies Ltd has informed BSE that:"Mr. Shaleen Kumar, of Investment Research Team of UBS Securities India, would be meeting our General Manager-Finance, Mr. Sachin Salvi, at our office at Turbhe, Navi Mumbai by 10.00 A.M. on Monday, December 26, 2016. He may be accompanied by their India-Head of Equity Sales and/or a few other colleagues, and the timing is subject to change due to any exigency of situation.... Updates
Thyrocare Technologies Ltd has informed BSE that Ms. Amisha Vora & Mr. Dilip Bhat, Joint Managing Directors, and Mr. Vishal & Mr. Shankar, Co-Heads-Equities, of Prabhudas Lilladher Pvt. Ltd. would be meeting the Company's Chairman & Managing Director, Dr. A. Velumani, at the Company's office at Turbhe, Navi Mumbai by 3.00 P.M. on December 22, 2016.... Updates
Thyrocare Technologies Ltd has informed BSE that Company's Chairman & Managing Director, Dr. A. Velumani, has been invited to participate at Spark Healthcare Conference 2016, organized by M/s. Spark Capital Advisers (India) Pvt. Limited, at a prestigious location in BKC, on December 13, 2016, where they expect to host about 20 healthcare companies, with expected participation from about 75 investors, representing Mutual Funds, Insurance Companies,... Updates
Thyrocare Technologies Ltd has informed BSE that Mr. Sarath Sathkumara, Managing Director, Taiyo Pacific Partners, USA, would be meeting our General Manager-Finance, Mr. Sachin Salvi. at our office at Turbhe, Navi Mumbai by 4.30 P.M. on December 20, 2016. The meeting is being organized by Stockpro Advisers.Further, he might be accompanied by a few colleagues and/or representative(s) of Stockpro Advisers at the meeting and the timing is subject to change due to any exigency of situation.